Tokyo, Japan – Researchers from Tokyo Metropolitan University have shown that the protein Musashi-2 (Msi2) plays a key role in the regulation of mass and metabolic processes in skeletal muscle. They ...

(RTTNews) - AEON Biopharma, Inc. (AEON), a biopharmaceutical company that develops ABP-450 as a biosimilar to BOTOX, reported that it held a BPD Type 2a meeting with the FDA in addition to the closure ...